Tannic Acid Attenuates Quinolinic Acid-Induced Neurodysfunction by Modulating Oxidative Stress and Pump Activity In vitro

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

The pathophysiology of neurodegenerative illnesses is largely dependent on oxidative stress and poor ion homeostasis, and these conditions represent a substantial worldwide health burden. Endogenous neurotoxic quinolinic acid (QA) is linked to neurodysfunction by inducing oxidative stress and interfering with sodium pump function. In a number of models, the polyphenolic molecule tannic acid (TA), which has strong antioxidant qualities, has demonstrated pharmacological effects in several diseased conditions. However, the neuroprotective effect of tannic acid is rather speculative and still very open for clarification. In the present study, an in vitro model was employed to examine the effect of tannic acid on deoxyribose degradation, lipid peroxidation, thiol status, antioxidant enzymes, and cerebral and spinal sodium pump in rat cerebral and spinal tissue homogenates treated with quinolinic acid (2 mM). Results revealed that quinolinic acid treatment led to a profound ( p  < 0.05) degradation of deoxyribose, formation of thiobarbituric acid reactive substances, and marked reduction ( p  < 0.05) in tissue level of free thiols. However, tannic acid treatment significantly ( p  < 0.05) counteracted thiobarbituric acid reactive substances production, deoxyribose degradation and markedly increased ( p  < 0.05) the thiol level of the cerebral and spinal tissue homogenates. Furthermore, quinolinic acid markedly ( p  < 0.05) diminished the activities of cerebral and spinal antioxidant enzymes, such as catalase, superoxide dismutase, glutathione peroxidase, and glutathione S -transferase, and impaired the activities of cerebral and spinal sodium pump. Nonetheless, the activities of the antioxidant enzymes and pump were all raised in both the cerebral and spinal tissue homogenates upon tannic acid treatment. These findings justify the pharmacological action of tannic acid on quinolinic acid-induced neurotoxicity and suggest its potential use in the treatment of neurodegenerative diseases.

Article activity feed